iBio Inc, IBIO Securities Lawsuit

Company:	iBio Inc,
Ticker Symbol:	IBIO
Class Period:	Oct-13-14 to Oct-23-14
Date Filed:	Dec-16-14
Lead Plaintiff Deadline:	Feb-14-15
Court:	District of Delaware
Allegations:

Los Angeles, CA: A securities class action lawsuit has been commenced in the United States District Court for the District of Delaware on behalf of investors who purchased iBio, Inc. ("iBio" or the "Company") (NYSE MKT:IBIO) securities between October 13, 2014 and October 23, 2014.

The Complaint alleges that during the Class Period, the Company issued materially false and misleading statements to investors by wrongfully suggesting that the Company's Launch platform patents and related proprietary technology would be licensed by the makers of the experimental Ebola drug, ZMapp. The Complaint alleges that when the true facts were revealed, the price of the Company's stock fell significantly, damaging investors.



If you acquired the securities of the defendants during the Class Period you may, no later than the Lead Plaintiff Deadline shown above, request that the Court appoint you as lead plaintiff through counsel of your choice. You may also choose to remain an absent class member. A lead plaintiff must meet certain requirements.

iBio Inc, IBIO Securities Fraud Legal Help

If you have suffered from financial losses, you may qualify for damages or remedies that may be awarded in a possible iBio Inc, securities class action lawsuit. Please click the link below to submit your complaint for a free evaluation.